Expression of p14ARF, p15INK4b, p16INK4a, and DCR2 increases during prostate cancer progression

Modern Pathology

Volumn 19, Issue 10, 2006, Pages 1339-1343

  Zhang, Zhihong ^a   Rosen, Daniel G ^a   Yao, Jorge L ^b   Huang, Jiaoti ^b   Liu, Jinsong ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

DCR2; p14ARF; p15INK4b; p16 INK4a; Prostate carcinoma; Senescence marker

Indexed keywords

DECOY RECEPTOR 2; PROTEIN; PROTEIN P14; PROTEIN P15; PROTEIN P16; UNCLASSIFIED DRUG; CYCLIN DEPENDENT KINASE INHIBITOR 2B; PROTEIN P14ARF; PROTEIN P16INK4A; TNFRSF10D PROTEIN, HUMAN; TUMOR MARKER; TUMOR NECROSIS FACTOR DECOY RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; CANCER GROWTH; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPEROXIDASE STAINING; MAJOR CLINICAL STUDY; NODULAR HYPERPLASIA; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE CARCINOMA; PROTEIN EXPRESSION; TISSUE MICROARRAY; ADENOCARCINOMA; CELL TRANSFORMATION; COMPARATIVE STUDY; MALE; METABOLISM; PATHOLOGY; PROSTATE HYPERTROPHY; PROSTATE TUMOR; PROSTATIC INTRAEPITHELIAL NEOPLASIA; RETROSPECTIVE STUDY;

ADENOCARCINOMA; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PROSTATIC HYPERPLASIA; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; RECEPTORS, TUMOR NECROSIS FACTOR; RETROSPECTIVE STUDIES; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR NECROSIS FACTOR DECOY RECEPTORS; TUMOR SUPPRESSOR PROTEIN P14ARF;

EID: 33748869724     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800655     Document Type: Article

References (26)

1. Kim HJ, Jung KJ, Yu BP, et al. Modulation of redox-sensitive transcription factors by calorie restriction during aging. Mech Ageing Dev 2002;123:1589-1595.
2. Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res 1961;25: 585-621.
3. Choi J, Shendrik I, Peacocke M, et al. Expression of senescence- associated beta-galactosidase in enlarged prostates from men with benign prostatic hyperplasia. Urology 2000;56:160-166.
4. Incles CM, Schultes CM, Kempski H, et al. A G-quadruplex telomere targeting agent produces p16-associated senescence and chromosomal fusions in human prostate cancer cells. Mol Cancer Ther 2004; 3:1201-1206.
5. Sherr CJ. Cancer cell cycles. Science 1996;274: 1672-1677.
6. Jin M, Piao Z, Kim NG, et al. p16 is a major inactivation target in hepatocellular carcinoma. Cancer 2000;89: 60-68.
7. Michaloglou C, Vredeveld LC, Soengas MS, et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 2005;436:720-724.
8. Haber DA. Splicing into senescence: the curious case of p16 and p19ARF. Cell 1997;91:555-558.
9. Nguyen TT, Nguyen CT, Gonzales FA, et al. Analysis of cyclin-dependent kinase inhibitor expression and methylation patterns in human prostate cancers. Prostate 2000;43:233-242.
10. Quelle DE, Zindy F, Ashmun RA, et al. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 1995;83:993-1000.
11. Kamijo T, Zindy F, Roussel MF, et al. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 1997; 91:649-659.
12. Hannon GJ, Beach D. p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 1994; 371:257-261.
13. Liu X, Yue P, Khuri FR, et al. Decoy receptor 2 (DcR2) is a p53 target gene and regulates chemosensitivity. Cancer Res 2005;65:9169-9175.
14. Shivapurkar N, Toyooka S, Toyooka KO, et al. Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types. Int J Cancer 2004;109:786-792.
15. Collado M, Gil J, Efeyan A, et al. Tumour biology: senescence in premalignant tumours. Nature 2005; 436:642.
16. Huang J, Yao JL, Zhang L, et al. Differential expression of interleukin-8 and its receptors in the neuroendocrine and non-neuroendocrine compartments of prostate cancer. Am J Pathol 2005;166:1807-1815.
17. Meng RD, McDonald III ER, Sheikh MS, et al. The TRAIL decoy receptor TRUNDD (DcR2, TRAIL-R4) is induced by adenovirus-p53 overexpression and can delay TRAIL-, p53-, and KILLER/DR5-dependent colon cancer apoptosis. Mol Ther 2000;1:130-144.
18. Schwarze SR, Shi Y, Fu VX, et al. Role of cyclin-dependent kinase inhibitors in the growth arrest at senescence in human prostate epithelial and uroepithelial cells. Oncogene 2001;20:8184-8192.
19. Jarrard DF, Sarkar S, Shi Y, et al. p16/pRb pathway alterations are required for bypassing senescence in human prostate epithelial cells. Cancer Res 1999; 59:2957-2964.
20. Reznikoff CA, Yeager TR, Belair CD, et al. Elevated p16 at senescence and loss of p16 at immortalization in human papillomavirus 16 E6, but not E7, transformed human uroepithelial cells. Cancer Res 1996;56: 2886-2890.
21. Hara E, Smith R, Parry D, et al. Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol Cell Biol 1996; 16:859-867.
22. Sandhu C, Donovan J, Bhattacharya N, et al. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells. Oncogene 2000;19:5314-5323.
23. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science 1998;281:1305-1308.
24. Kelley SK, Ashkenazi A. Targeting death receptors in cancer with Apo2L/TRAIL. Curr Opin Pharmacol 2004;4:333-339.
25. Greenlee RT, Hill-Harmon MB, Murray T, et al. Cancer statistics, 2001. CA Cancer J Clin 2001;51:15-36.
26. Chen F, Li Y, Lu Z, et al. Adenovirus-mediated Ink4a/ARF gene transfer significantly suppressed the growth of pancreatic carcinoma cells. Cancer Biol Ther 2005;4:1348-1354.